Clinical Trial

MDR Vivacit-E Elevated Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-29; most recent amendment 2026-03-31.
Trial Details
NCT Number NCT07150221
Lead Sponsor Zimmer Biomet
Conditions Osteoarthritis (OA) of the Hip, Avascular Necrosis of Bone of Hip, Protrusio Acetabuli, Traumatic Arthropathy-Hip, Slipped Capital Femoral Epiphyses, Fused Hip, Fracture of Pelvis, Diastrophic Variant
Enrollment 52 participants
Start Date 2026-01-07
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-01